Pharming to present at Bio-Europe 2009

Pharming to present at Bio-Europe 2009

ID: 7423

(Thomson Reuters ONE) - Leiden, The Netherlands, October 26, 2009. Biotech company PharmingGroup NV ("Pharming") (NYSE Euronext: PHARM) today announced that itwill present at the 15th BIO-Europe (November 2-4, 2009) in Vienna,Austria.Sijmen de Vries, Chief Executive Officer of Pharming, will present anupdate of the Company and its business at the BIO-Europe conferenceon Tuesday, November 3 at 11:00 am Central European Time. BIO-Europeis Europe's largest international partnering conference. Theconference attendees include delegates from Europe, North America andAsia-Pacific. For further information on the BIO-Europe 2009, pleasevisit http://www.ebdgroup.com/bioeurope.The presentation will be available on Pharming's website after themeeting.About Pharming Group NVPharming Group NV is developing innovative products for the treatmentof genetic disorders, ageing diseases, specialty products forsurgical indications, and nutritional products. Pharming's leadproduct Rhucin® for acute attacks of Hereditary Angioedema has passedclinical development stage and the Market Authorization Applicationis under review with EMEA. Prodarsan® is in early stage clinicaldevelopment for Cockayne Syndrome and lactoferrin for use in foodproducts The advanced technologies of the Company include innovativeplatforms for the production of protein therapeutics, technology andprocesses for the purification and formulation of these products, aswell as technology in the field of DNA repair (via DNage). Additionalinformation is available on the Pharming website,http://www.pharming.com.This press release contains forward looking statements that involveknown and unknown risks, uncertainties and other factors, which maycause the actual results, performance or achievements of the Companyto be materially different from the results, performance orachievements expressed or implied by these forward lookingstatements.Contact:Ms. Marjolein van Helmond, Pharming Group NV, T: +31 (0)71 52 47 431or +31 (0)6 109 299 54http://hugin.info/132866/R/1350070/325598.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.



Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Walter Fust stepping down from Board of Directors Net Asset Value(s) - CORRECTION
Bereitgestellt von Benutzer: hugin
Datum: 26.10.2009 - 18:00 Uhr
Sprache: Deutsch
News-ID 7423
Anzahl Zeichen: 0

contact information:
Town:

London



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 313 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Pharming to present at Bio-Europe 2009"
steht unter der journalistisch-redaktionellen Verantwortung von

Pharming Group N.V. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Pharming confirms interaction with US FDA for Rhucin ...

Leiden, The Netherlands, December 9, 2009. Biotech company Pharming Group NV ("Pharming") (NYSE Euronext: PHARM) today confirmed its interactions in a pre-BLA meeting with the US Food and Drug Administration (FDA) on a pr ...

Alle Meldungen von Pharming Group N.V.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z